The situation
The contract in dispute was worth about six hundred thousand dollars a year, a three-year supply agreement that made up roughly a tenth of the company's total purchasing. That was the number a newly admitted investor pointed to when he demanded the agreement be unwound, arguing it had never been properly authorized in the first place. For Abena and Vasyl, co-founders of a St. Thomas company doing close to ten million dollars in annual revenue, the number mattered less than what losing the fight would say about how their board actually operated.
The supply agreement in question was with a packaging business owned by Vasyl's brother, Andriy, an actuary by training who had left insurance work several years earlier to run the supplier full time. When the company's operations team first identified Andriy's business as the strongest bidder for a packaging contract, Vasyl knew immediately that his relationship to the supplier put him in a position where the company's rules required him to say so formally before the board decided anything.
Vasyl did not go to a lawyer first. He searched online, found a generic explainer about director conflicts written for a different jurisdiction, and came away with the impression that simply mentioning the relationship out loud during the meeting, and not voting on the resolution, was enough. He disclosed the connection, said he would abstain, and then stayed at the table for the rest of the discussion, weighing in on pricing terms before the board voted to approve the contract with Andriy's company. Abena, occupied at the time with a commercial pilot's schedule she still kept on the side and unfamiliar herself with the finer points of corporate procedure, did not think to question the process.
The contract ran for over a year without incident until the company brought on a new minority investor as part of a financing round. Reviewing the company's minute book as part of due diligence, the investor's own advisor flagged the packaging contract and the family relationship behind it, and within weeks the investor was arguing that the contract had never been validly authorized and should be set aside, with the company entitled to recover what it had already paid.
For Abena and Vasyl, the timing could hardly have been worse. The financing round that brought the new investor in had closed only two months earlier, and the relationship was still finding its footing. A dispute over governance, raised this early, threatened to colour how the investor viewed the company's management generally, well beyond the value of the packaging contract itself, and both founders were conscious that how they responded would matter as much as the legal merits of the challenge.
What the other side was relying on
The investor's position rested on a real and well-established principle: a director with a personal interest in a contract the company is entering into cannot simply announce the conflict and carry on as before. Ontario corporate law requires a director in that position to disclose the nature and extent of the interest, and, for the contract to stand on the strength of board approval alone, to refrain from voting and, in most circumstances, from being present for the part of the discussion where the matter is debated and decided. The purpose of the rule is not to punish the relationship itself but to make sure the remaining directors negotiate and decide the terms without the interested director's presence shaping the conversation.
The investor's advisor argued that Vasyl's continued presence at the table during the pricing discussion, even without a vote, meant the safeguard had not been properly followed, and that this exposed the contract to being challenged as invalid or, at minimum, meant Vasyl could be required to account for any profit his brother's business had made from it. That argument, taken alone, was not unreasonable. Minute books that show a director disclosing an interest but remaining fully engaged in the discussion are a common and genuine problem, and courts have set aside board decisions, or required an accounting, in situations that looked a great deal like this one on paper.
What the investor's argument did not account for was what actually happened next, which the minute book, read carefully, also showed. Roughly six weeks after that first meeting, and before the contract was signed, Abena had raised the process with outside counsel while dealing with an unrelated matter, and the board had gone back and formally redone the approval, this time with Vasyl disclosing the conflict, leaving the room entirely for both the discussion and the vote, and the remaining independent director approving the terms on the record without him present. The investor's challenge was built on the first, flawed meeting, and either had not seen the second one or had chosen to treat it as insufficient to cure the original defect.
The question for us was not whether the first meeting had been done wrong. It plainly had. The question was whether the second, corrected approval was sufficient on its own to validate the contract, independent of the earlier misstep, and whether the passage of time and part-performance of the contract by both sides added any further support to that position.
What we did
- Pulled the full minute book for both board meetings, not just the one the investor's advisor had flagged, to establish precisely what had happened at each stage, since the strength of the company's position depended entirely on the second meeting having cured the defect in the first. We also checked the corporate secretary's working notes against the signed minutes, to be sure nothing material had been tidied up after the fact.
- Confirmed that the second meeting met every element of a proper interested-director approval, including that Vasyl had disclosed the specific nature of his interest, that he had left the room for both the discussion and the vote, and that the remaining director had approved the contract on terms that were, on their face, commercially reasonable rather than favourable to Vasyl's brother.
- Assessed whether the earlier, defective meeting undermined the second one, concluding that because the contract had not yet been signed at the time of the first meeting, the board's later, properly conducted approval was the operative decision, and the flawed first meeting was better understood as an aborted first attempt than as the governing corporate act. This distinction mattered because a defect cured before signing is a different problem, legally, than one discovered afterward.
- Reviewed the pricing terms Andriy's company had offered against two comparable bids the operations team had also solicited at the time, confirming the packaging contract had, in fact, been the most competitive of the three, which supported the argument that the deal reflected sound business judgment rather than favouritism, even though that point alone would not have cured a genuine procedural defect.
- Drafted a detailed response to the investor's advisor setting out the full sequence of events, attaching the minutes from both meetings, and explaining why the second approval was legally sufficient on its own, while acknowledging candidly that the first meeting had not been handled correctly, which we judged more persuasive than disputing a point that was not actually in dispute.
- Advised the board on tightening its conflict procedure going forward, including a standing rule that any director with a personal interest in a matter leaves the room for the entire discussion, not only the vote, and that the corporate secretary record the departure and return times in the minutes as a matter of course. The rule was written to apply automatically, so no future board had to rediscover the same lesson under pressure.
- Prepared Abena and Vasyl for the possibility of a formal legal challenge if the investor was not satisfied with the written response, including an assessment of the company's prospects if the matter proceeded further, so the board could weigh a negotiated resolution against the cost and disruption of a drawn-out dispute with a minority investor. That assessment gave both founders a clear-eyed sense of their actual leverage rather than a guess.
- Advised on how to communicate the fix to the investor beyond the strict legal response, recommending a short follow-up conversation between Abena and the investor once the written record had been reviewed, so the resolution did not land purely as a legal defence but also rebuilt some of the trust the episode had strained. A legal win on paper does not automatically repair a working relationship.
The outcome
The investor's advisor withdrew the challenge after reviewing the full record, accepting that the second board meeting had properly cured the defect in the first and that the contract stood on solid footing. No payment was returned, no accounting was required, and the packaging contract continued on its original terms through the remainder of its three-year term. The company avoided both the direct legal cost of a formal challenge and the harder-to-measure cost of a fight with a new investor so early in the relationship.
The episode did leave a mark on how the board operated afterward. The standing rule requiring a fully documented departure from the room, not just an abstention from voting, was adopted at the next board meeting and has governed every interested-party transaction since, including two further contracts where Andriy's company was not involved at all but another director had a smaller personal stake.
Vasyl, in hindsight, was candid that the online explainer he had relied on early in the process had come close to costing the company far more than it saved him in a lawyer's time. Abena's decision to raise the process with outside counsel before the contract was signed, rather than after a dispute arose, turned out to be the single step that made the difference between a valid contract and a contract that could have been unwound entirely.
The relationship with the investor also recovered faster than either founder expected. The follow-up conversation Abena had, separate from the written legal exchange, addressed the underlying discomfort about a director's family member benefiting from a company contract, even where the process had ultimately been followed correctly. Roughly a year later, the investor participated in a second financing round without raising the episode again, which both founders took as a sign that the governance fix had done more than avert legal exposure. It had also repaired confidence in how the board managed conflicts generally.
What you can learn from this
- Disclosing a conflict of interest is only the first step. A director with a personal stake in a decision generally also needs to leave the room for the discussion and the vote, not just abstain from voting while staying at the table.
- General information found online is often written for a different jurisdiction or a different type of organization. It is a starting point for questions, not a substitute for advice on your own company's situation.
- A defective board approval can sometimes be cured by redoing it properly before the underlying contract is signed. Waiting until after signing, or after a dispute arises, removes that option.
- Keeping minutes that record exactly when an interested director left and returned to a meeting is a small habit that can be the difference between a contract standing and a contract being unwound.
- A commercially competitive deal does not excuse a flawed approval process, but evidence that the terms were fair can support a company's position once the process itself has been properly corrected.
This is a corporate problem we handle
Start a file online — flat, published fees, reviewed by a licensed lawyer before a dollar is owed.